ASKA Pharmaceutical Holdings (4886) · InitiativeFirst statedLatest Governance (2026-06-29): "Restated"

Transition to a company with an audit and supervisory committee

First written in FY2026. 5 of 11 entries say "Advanced", first in 2026-05-11. Latest entry: 2026-06-29.

11entries

1years

10from disclosures

How it moved

Same theme, other companies

Transition to a company with an audit and supervisory committeeA theme 787 companies write about · 0 as a headwind · 796 as a tailwind

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 796 threads.

Full recordFilings, disclosures and news, newest first

FY2026First statedAnnual report
「当該議案が承認可決されますと当社は監査等委員会設置会社に移行いたします。」
2026年6月24日開催予定の定時株主総会での定款変更承認を条件に、監査等委員会設置会社へ移行し、監査等委員である取締役が取締役会で議決権を持つ体制を初めて記載している。

Moved together

"Inclusion of the Management Philosophy in the Articles of Incorporation and Asuka’s Unique Value Creation" moved the same way as this thread, in the same document, in 2 of its 10 moves.

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next

ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview It last moved in the Governance of 2026-06-29: "Restated".

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.